Aurinia Pharmaceuticals Inc.·4

Nov 23, 4:04 PM ET

Donley Matthew Maxwell 4

4 · Aurinia Pharmaceuticals Inc. · Filed Nov 23, 2022

Insider Transaction Report

Form 4
Period: 2022-11-21
Donley Matthew Maxwell
Chief Operating Officer
Transactions
  • Purchase

    Common Stock

    2022-11-21$4.66/sh+10,000$46,60027,927 total
Footnotes (1)
  • [F1]Includes 1,703 common stock of the Issuer acquired by the reporting person on May 31, 2022 pursuant to the Company's 2021 Employee Stock Purchase Plan.

Documents

1 file
  • 4
    wf-form4_166923742713580.xmlPrimary

    FORM 4